But the data emerging from the TRIUMPH program is shaping the future of obesity medicine
Whats more, some wellness and longevity clinics, as well as doctors offices, are skirting regulations and offering injectable GHK-Cu off-label for all-over aging, post-procedure wound healing, and in scalp treatments to address hair thinningbut again, the evidence for systemic use is scant and currently restricted
Weight loss from GLP-1 therapy includes some loss of lean body mass, with studies suggesting that approximately Short-term clinical trials have generally shown preserved muscle strength despite reductions in lean mass, and some studies suggest these medications may improve muscle quality by reducing fat infiltration within muscle tissue
Before stopping any medication, obtain clearance from your prescribing healthcare provider
Mechanism of Action: GLP-1 receptor agonists work through multiple physiological pathways: Central appetite suppression : These medications cross the blood-brain barrier and activate GLP-1 receptors in the hypothalamus and brainstem, reducing hunger signals and increasing satiety Gastric emptying delay : By slowing stomach emptying, patients experience prolonged fullness after meals Insulin secretion enhancement : Glucose-dependent insulin release improves glycemic control Glucagon suppression : Reduced glucagon secretion decreases hepatic glucose production Tirzepatide offers dual agonism at both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, potentially providing enhanced weight loss efficacy compared to single-agonist medications
Up to 10-15% of your hair is in this stage at any given time, shedding at a rate of 50-100 strands daily
